{"id":"W4306411260","doi":"10.1002/clc.23926","title":"Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD","year":2022,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Esperion Therapeutics; Insmed; Moderna; Agios Pharmaceuticals; ARCA Biopharma; Cook Medical; Regeneron Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Prothena; Alexion Pharmaceuticals; Yale University; Alnylam Pharmaceuticals; Brigham and Women's Hospital; Kowa Company; Sanofi; Audentes Therapeutics; Amgen; Pfizer","keywords":"Medicine; Rivaroxaban; Hazard ratio; Amputation; Surgery; Myocardial infarction; Aspirin; Revascularization; Stroke (engine); Population; Internal medicine; Critical limb ischemia; Confidence interval; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007439955,0.002256134,0.00430184,0.0005875872,0.0004187256,0.001359156,0.001307899,0.001485857,0.005247922],"category_scores_gemma":[0.007743562,0.0004517917,0.00759986,0.0004059234,0.001310275,0.001065497,0.0007253168,0.002743854,0.0005659247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008811925,"about_ca_system_score_gemma":0.001253259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006198623,"about_ca_topic_score_gemma":0.0005686106,"domain_scores_codex":[0.9948848,0.003369851,0.0002568002,0.000690436,0.0002772166,0.0005209644],"domain_scores_gemma":[0.9917882,0.004938805,0.001299571,0.0009883658,0.0003595859,0.0006254893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9805844,0.00349321,0.003865283,0.0003415718,0.005793611,0.00008253992,0.00005810256,0.0007860906,0.001334512,0.00008332991,0.0005823926,0.002994991],"study_design_scores_gemma":[0.4274727,0.4756961,0.06718472,0.00009034969,0.01423745,0.0002208331,0.0002095263,0.006865499,0.005367819,0.0008100829,0.001696785,0.000148147],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966203,0.0005928407,0.0004884985,0.0001202867,0.0002239572,0.0005724902,0.0007696669,0.00004320473,0.0005687754],"genre_scores_gemma":[0.9956032,0.0002176049,0.0005655468,0.0002181863,0.0002638824,0.001284895,0.0009818925,0.0000200942,0.0008448493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007439955,"threshold_uncertainty_score":0.03934669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05346899791071398,"score_gpt":0.3472235257317107,"score_spread":0.2937545278209967,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}